Received Date: August 20, 2015; Accepted Date: December 01, 2015; Published Date: December 04, 2015
Citation: Patra S, Nithya S, Srinithya B, et al. Review of Medicinal Plants for Anti-Obesity Activity. Transl Biomed. 2015, 6:3. doi: 10.21767/2172-0479.100021
Obesity is a complex health issue to address, it is a serious and chronic disease that can have a negative effect on many systems in your body. Overweight and obesity may increase the risk of many health problems, including diabetes, heart disease, osteoarthritis and certain cancers. Obesity is increasing at an alarming rate throughout the world. Today it is estimated that there are more than 300 million obese people world-wide. Obesity is regarded as a disorder of lipid metabolism and the enzymes involved in this process could be targeted selectively for the development of antiobesity drugs. However, most of the anti-obesity drugs that were approved and marketed have now been withdrawn due to serious adverse effects. The naturopathic treatment for obesity has been explored extensively since ancient times and gaining momentum in the present scenario. Traditional medicinal plants and their active phytoconstituents have been used for the treatment of obesity and their associated secondary complications. Some active medicinal plants and their respective bioactive compounds were also tested by clinical trials and are effective in traemnet of obesity. This review focus on natural phytoextracts with their mechanism of action and their preclinical experimental model for further scientific research.
Obesity; Antiobesity drugs; Medicinal plants
In the present scenario, obesity is the major public health problem with about 1.9 billion adults (18 years and older) worldwide are overweight and about 600 million of them are clinically obese . Obesity is characterized by increase in adipose cell size which is determined by amount of fat accumulated in the cytoplasm of adipocytes . This change in the metabolism in the adipocytes is regulated by various enzymes such as fatty acid synthase, lipoprotein lipase and adipocyte fatty acid-binding protein .
Obesity results from an imbalance between energy intake and expenditure. It is caused by altered lipid metabolic processes including lipogenesis and lipolysis . Lipogenesis is the process that stores free fatty acids in the form of triglyceride (TG) ; similarly, lipolysis is the process whereby the TG stored is metabolized to free fatty acids and glycerol . Obesity accompanied by hyperlipidemia which is indicated by abnormally high concentration of lipids in blood . The adipose tissue, an endocrine organ, has a major role in the regulation of metabolism and homeostasis, through the secretion of several biologically active adipokines . During adipose tissue development, three major transcription factors, peroxisome proliferator-activated receptor (PPAR) γ, CCAAT/enhancer binding protein (C/EBP) α, and sterol regulatory element-binding protein (SREBP) 1c, regulate the expression of these lipid-metabolizing enzymes . 5' AMPactivated protein kinase (AMPK) plays a major role in glucose and lipid metabolism by inactivating acetyl-CoA carboxylase (ACC) and stimulates fatty acid oxidation by up-regulating the expression of carnitine palmitoyltransferase-1 (CPT-1), PPARα, and uncoupling protein .
Nowadays, changes in human lifestyle and high energy diet have increased the incidence of obesity and even have become a risk factor to the population of children [11,12]. There are several pharmacologic substances available as antiobesity drugs, however they have hazardous side effects and hence natural products have been used for treating obesity in many Asian countries . The potential of natural products for the treatment of obesity is still largely unexplored and can be an excellent alternative for the safe and effective development of antiobesity drugs .
Currently drugs available in the market for treatment of obesity can be divided into two major classes one being orlistat, which reduces fat absorption through inhibition of pancreatic lipase and the second is subutramine which is an anorectic or appetite suppressant. Both drugs have adverse effects including increased blood pressure, headache, drymouth, insomnia, and constipation [15,16]. In 1990 Fenfluramine and Dexfenfluramine were withdrawn from the market because of heart valve damage .
The US FDA in 1997 approved subutramine drug as a treatment for obesity. But later in October 2010 the drug was withdrawn from the market due to increased cardiovascular events and strokes [18,19]. In February 2011 the US FDA rejected approval of contrive which is a combination of bupropion/naltrexone due to concerns over potential cardiovascular risks . Certain drugs have potential for abuse such as phentermine and diethylpropion and hence are approved for short term use .
At present, because of high cost and potentially hazardous side effects, the need for natural products against obesity is under exploration which may be an alternative strategy for developing effective, safe antiobesity drugs . In 2000, Moro and Basile reported the use of certain well known medicinal plants that had claimed to be useful in treating obesity. The antiobesity effects of natural products from more diverse sources . The aim of the present review was to update data on potential antiobesity herbal plants.
Databases used for this study to search include PubMed, Scopus, Google Scholar, Web of Science, and IranMedex with information reported between September 2, 2006 to September 22, 2014. Search of literatures was focused on human or animals investigating the benefits and harms of herbal medicines to treat obesity. The search terms were “obesity” and (“herbal medicine” or “plant”, “plant medicinal” or “medicine traditional”) without narrowing or limiting search items. Publications with abstract from the mentioned databases were used to prepare this review. The main outcome measures were defined as body weight, body fat, including fat mass/fat weight or fat percentage/visceral adipose tissue weight, waist or hip circumference, triceps thickness and appetite, and the amount of food/energy intake. Abstracts of publications on plants used to evaluate the activity on human, animals, cell lines studies with the main outcome as mentioned above were included. In vitro studies, review articles and letters to the editor were excluded. Two reviewers reviewed the articles for abstracts and title. Due to our inclusion and exclusion criteria, the duplicate articles were eliminated. The review includes active components and mechanism of action against obesity in animals and presented in Table 1. Some of the plants are tested for their activity against obesity in cell lines listed in Table 2 and plants that were tested on human volunteers or clinical trails are listed in Table 3. In some instances scientist have evaluated the anti-obesity activity in isolated cell organelles, isolated cellular enzymes specifically pancreatic lipase are listed in Tables 3 and 4 respectively. Table 4 present the plant which was studied for its activity against obesity in an in silico model.
|1Plant name||Part(s)||Mechanism||Experimental model||Reference|
|Seed||The plant lowers total cholesterol, total triglyceride, and LDL-cholesterol, and increases HDL cholesterol level.||High-fat-fed male Swiss albino mice|||
|Rhizome, roots and leaves||Ethyl acetate extarct of A. calamus inhibits α-glucosidase activity.||Glucose challenged mice.|||
|3.||Achyranthes bidentataBlume (Amaranthaceae)||Root||The drug affects on differentiation of adipocyte and decrease of phospho-Akt expression.||Male Sprague-Dawley fed with a high-fat diet|||
|Fruits||Serum levels of aspartatedecreased in the mice treated with the extract without changes in serum levels of alanine transaminaseblood urea nitrogen and creatinine.||Mice with high-fat dietinducedobesity|||
|Root||Anti-obesity effect of A. triphyllais mediated by increasing adipocytesadiponectin and activating pathway like AMPK, and PPAR-α, and decreasingadipokines TNF-α, GPDH, and PPAR-α. It also actively expresses low-density lipoprotein [LDL] receptor and cholestorl 7α- hydroxylase (CYA7A1) and inhibitsexpression of 3 hydroxy-3 methyl glutaryl - CoA (HMG-CoA)reductase.||High fat diet (HFD)- C57B2/6 mice||[28,29]|
|.6||Aegle marmelosLinn (Rutaceae)||Leaves||The active chemical constituents of A. marmelosfor anti-adipogenic activity are halfordinol, ethyl ether aegeline and esculetin were responsible for the decrease in adipocyte accumulation. Active compounds umbelliferone and esculetin depletes lipid content in the adipocytes and by decreasing the hyperlipidemia.||High fat diet induced obese male Sprague Drawly rat||[30,31]|
|Peel||The mRNA levels of activating protein (AP2) is down-regulated by A.cepa and those of carnitine palmitoyl transferase-1 α (CPT-1α) and fatty acid binding protein 4 (FABP4) are up-regulated. It is also proposed that A. cepa increases level of PPAR-γ2 mRNA (mesenteric fats) and IL-6 mRNA levels (perirenal and mesenteric fats).||High fat-fed rats, Diet-induced obese Male Sprague-Dawley rats||[32,33]|
|Root||Significant reduction in body weight and adipose tissue weight as well as adipocyte size. Genes involved in lipogenesis are down-regulated by A. fistulosum.||High fat diet- induced mice|||
|9||Allium nigrumLinn (Amaryllidaceae)||Bulb||Extract of A. nigrum upregulates AMPK, FOXO1, Sirt1, ATGL, HSL, perilipin, ACO, CPT-1, and UCP1 in the adipose tissues, whereas it downregulates CD36.||High-fat diet induced obese mice|||
|Stem, Bulb and Roots||It increases antioxidant enzymes and suppresses glutathione depletion and lipid peroxidation in hepatic tissue. Oil isolated from A. sativum down regulates sterol regulatory element binding protein-1c, acetyl-coA carboxylase, fatty acid synthase, and 3-hydroxy-3- methylglutaryl-coenzyme A reductase.||High-fat diet-induced obese C57BL/6J mice||[36,37]|
|Rhizome||Galangin, the principal compontent of A. galangal decreases serum lipids, liver weight, lipid peroxidation and accumulation of hepatic TGs.||Obesity induced in female rats by feeding cafeteria diet|||
|12||Alpinia officinarum Hance (Zingiberaceae)||Root||The drug controls and improves lipid profile in animals by lowering serum Total-C, TG, and LDL-C concentrations, leptin content.||Obesity in mice fed a high-fat diet||[39,40]|
|Roots||Decursin, the active constituent of A.gigas improves glucose tolerance. Decursin along with the HFD significantly reduces secretionadipocytokines such as leptin, resistin, IL-6 and MCP-1.||Mice fed a high-fat diet|||
|Root||Serum contents of leptin, total cholestrol, LDL, and triglycerides are reduced by A. speciosa.||Diet- induced obesity rats|||
|Whole Plant||It downregulates adipogenic transcription factors PPARγ2 and C/EBPα and their target genes CD36, aP2, and FAS. The extract decreases gene expression of proinflammatory cytokines includingTNFα, MCP1, IL-6, IFNα, and INFβ in epididymal adipose tissue and reduces plasma levels of TNFα and MCP1.||Mice fed a high-fat diet.|||
|16||Atractylodes lancea(Thunb.) DC
|Rhizome||Itinhibits human pancreatic lipase. A new polyacetylene,syn-(5E,11E)-3-acetoxy-4-O-(3-methylbutanoyl)-1,5,11-tridecatriene-7,9-diyne-3,4-diol has been isolated and identified and exhibits lipase inhibitory activity.||High-fat diet-induced obesity mice|||
|17||Aster pseudoglehni Lim, Hyun & Shin
|Leaves||It suppresses expression of adipogenesis-related genes including PPARγ, C/EBPα, andSREBP1c.||High fat diet induced-male C57BL/6J mice|||
|Stem and root barks||Extract ofE. variegataincreases brain serotonin level and high-density lipoprotein with a concomitant decrease in total cholesterol, triglycerides and low-density lipo protein.||Hypercaloric diet -induced mice|||
|19||Bergenia crassifolia(L.) Fritsch
|Leaves||Galloylbergenin derivatives 3,11-Di-O-galloylbergenin and 4,11-
di-O-galloylbergenin are found to be present in B. crassifoliamoderates anti-lipid accumulationactivities.
|Rats with high-calorie diet-induced obesity|||
|Leaf||The extracts reduces adipose tissue weight serum alkaline aminotransferase and lactate dehydrogenase activities. Serum triglyceride,total cholesterol, LDL-cholesterol level, atherogenic index and cardiac risk factors are decreasedin animals fed with leaf powder and serum HDL -cholestrol levels are increased.||High fat/ cholestrol diet- induced Male Sprague-Dawley rats.|||
|Root||The phytoconstituents compounds sitosterol found in this plant which is structurally similar to cholesterol has beensuggested to reduce cholesterol by lowering the level of LDL-cholesterol and cholesterol level decreasedsignificantly in plasma without any side effects.||High fat diet infemale Sprague-Dawley rats|||
|Stem bark||The extract and active constituent gemfibrozil reverses the effects of HFD treatment on serum parameters. This activity may be due to the inactivation of acetyl-coA carboxylase, as a result of AMPK activation that mediates thermogenesis and FAS inhibition.||Male, Wistar albino rats|||
|23||Anredera cordifolia (Ten.) Steenis
|Leaves||The extract suppresses lipid accumulation and down-regulatesPPARγ, CCAAT/enhancer binding protein α, SREBP, and their target genes. It also increases phosphorylation of AMPK.||High-fat diet-induced obese rats|||
|24||Brassica rapa L.
|Root||Lipolysis-related genes includingβ3-adrenergic receptor,hormone-sensitive lipase,adipose triglyceride lipase, anduncoupling protein are induced in white adipocytes of animals treated with extract of B. campestris.||High fat diet induced mice|||
|Whole Plant||The extract reducesbody weight gain induced through adipocyte differentiation.||High-fat diet to C57BL/6 mice|||
|26||Bursera grandiflora(Schltdl.) Engl
|Roots||B. grandifloraexerts anti-obesity activity by decreasing in the plasma-triglyceride levels.||Mice of the C57B1/6 strain withhypercaloric diet.|||
|Wax||C. finmarchicus reduces macrophage infiltration and downregulates expression of proinflammatory genes including tumor necrosis factor-α, interleukin–6, and monocyte chemoattractant protein–1, whereas up-regulates adiponectin expression.||C57BL/6J mice with high-fat diet|||
|Leaves||C. japonicacontrol insulin which is a modulator of lipid synthesis via sterol regulatory elementbinding protein-1c (SREBP-1c), decreased levels of insulin affects hepatic triglyceride synthesis.||High fat diet induced Sprague−Dawley rats|||
|29||Camellia oleifera Abel
|Fruit hull||Serumlevelsof total cholesterol and triacylglycerols are decreased but high-density lipoprotein cholesterol increased.Activity of fatty acid in animal liver is lowered by.||Male ICR mice were fed a HFD|||
|30||Camellia sinensis(L.) Kuntze
|Leaves, twigs and stems, flower buds||C. sinesis attenuates the gene expression of (SREBP-1c), fatty acid synthase and CCAAT/enhancer binding protein α. Extract found to reduce sICAM-1 release followed by nonpharmacological HGTE supplementation in db/db mice causing no adiponectin-inducing or antiadipogenic effects, reduced sICAM-1 release. Chakasaponin II from flower bud, suppresses mRNA levels of neuropeptide Y (NPY). The mRNA levels of adipogenic genes such as PPAR-γ, C/EBP-α, SREBP-1c, adipocyte fatty acid-binding protein, lipoprotein lipase and fatty acid synthase are decreased in C. Sinensis treated animals.||Albino rats fed on high-fat diet, diet-induced obesity in Female ddY mice, high fat induced- C57BL/6J-Lepob/ob mice, high fat diet- induced C57BL/6J mice||[58-64]|
|31||Cheilanthes albomarginata C.B. Clarke
|Rhizome||Extract of C. albomarginatalowers plasma triglyceride activity as well as reduces weight of adipose tissue.||High fat diet induced obese male Sprague Dawleyrats|||
|Seeds||C. quinoa extractattenuate mRNA levels of several inflammation markers including monocyte chemotactic protein-1, CD68 and insulin resistance osteopontin, plasminogen activator inhibitor-1 and it also reverses the effects of HF-induced downregulation of the uncoupling protein(s) mRNA levels in muscle.||Mice fed with standard low-fat or a high-fat diet|||
|33||Cirsium brevicauleA. Gray
|Leaves||C. brevicauleinhibits fatty acid synthase and suppress the differentiation and lipid accumulation and affecting transcription factors such as SREBP-1c, C/EBPα, and PPARγ known to control the fatty acid synthase expression.||C57BL/6 mice that were fed a high-fat diet|||
|34||Citrus reticulata Blanco
|Peel||mRNA expression levels of lipogenesis rrelated genes such as SREBP1c, FAS and ACC1 in the liver are lowered and the size of adipocytes are reduced.||High fat diet induced mice|||
|35||Citrus sunki(Hayata) Yu.Tanaka
|Peel||Phosphorylation levels of AMPK andacetyl-CoAcarboxylase are decreased.||High-fat dietinduced obese C57BL/6 mice|||
|36||Clerodendrum phlomidisL. f.
|Roots||It nhibits pancreatic lipase activity. The extract contains β-sitosterol.||High fat diet induced obesity in C57BL/6J mice|||
|37||Coccinia grandis (L.) Voigt
|Fruit||Reduces body weight, food intake, organ and fat pads weight and serum GLU, CHO, TRG, LDL and VLDL cholesterol levels and increases HDL levels.||Cafeteria diet and Atherogenic dietinduced obesity in female rats.|||
|38||Codonopsis lanceolata (Siebold & Zucc.) Benth. & Hook.f. ex Trautv
|Roots||Reduces weight of adipose pads and the serum levels of triglycerides, total cholesterol, and low density lipoprotein cholesterol.||High-calorie/high-fat-diet induced obesity Sprague-Dawley male rats|||
|Seed||C. arabicadiet supplementation can impair glucose tolerance, hypertension, cardiovascular remodeling, and nonalcoholic fatty liver disease.||High-carbohydrate, high-fat diet-fed Wistar male rats|
|40||Coleus forskohlii(Willd.) Briq.
|Root||C. forskohlii act as anti-obesisity drug by inhibiting dyslipidemia.||Diet-induced obesity in rats|
|Leaves||Liver tissue gene expression of gp91phox (NOX2) involved in oxidative stress is down-regulated by C. olitorius and genes related to the activation of β-oxidation like PPARα and CPT1A are up-regulated by the plant.||High fat diet - induced LDL receptor deficient mice|
|Whole plant||Anti-obesity activity of the C. ecalyculatais medicated by anorectic central action, facilitating binding to adenosine receptors, thereby promoting an extension of adrenalin.||Mice (albino, swiss strain) treated with cyclophosphamide|
|43||Cornus officinalis Siebold & Zucc.
|Rhizome||Platycodin D is the major component effective to activate AMPK-α. The extract reduces serum levels of aspartate transaminaseand alanine transaminase.||C57BL/6J mice were fed a HF diet|
|Fruit peel||C. melo reduces gain in body weight, serum lipid profile like total cholesterol, triglyceride, LDL-C level, atherogenic index and increases serum HDL-C levels.||High cholesterol diet induced in rats|
|45||Cyamopsis tetragonoloba(L.) Taub
|Beans||It decreases adipose triglyceride accompanied by enhancing activity of hormone-sensitive lipase-facilitating mobilization of depot fat.||High-fat-fed Wistar rats|
|Flower||By combined effect of decreased exogenous lipid absorption, normalization of hepatic PPAR-γ gene expression, suppression of pancreatic activity and SREBP-1c and FAS gene expression, and higher fecal triglyceride output.||Hyper caloric diet- male Sprague-Dawley rats.|
|47||Dioscoreae tokoronis Linn
|Root||It decreases triglyceride, total plasma cholesterol, and low-density lipoprotein-cholesterol.It suppresses the expression of SREBP-1 as well as that of fatty acid synthase in adipose and liver tissues.||High fat diet - induced mice|
|Leaves, Bark||Asperuloside increases adenosine5′-triphosphate production in WATand increases use of ketone bodies/glucose in skeletal muscle.||Obesity induced by ovariectomy in female Wistar rats, rats fed a high-fat diet.|
|49||Fraxinus excelsior L.
|Seed||Secoiridoids present enhances fat metabolism through β-oxidation, inhibit adipocyte differentiation during animal growth and limit fat accumulation.||High fat diet induced mice|
|50||Garcinia cowa Roxb. ex Choisy
|Fruit, commercially available tablet||Inhibits the enzyme ATP-dependent citrate lyase, which catalyzes the cleavage of citrate to oxaloacetate and acetyl-CoA.Serum apo A1 levels are increased by the plant and the serum total cholesterol levels.||Female Sprague-Dawley rats fed atherogenic diet|
Siebold ex Lindl. & Paxton
|Leaf||The extract ameliorates high-fat diet-induced obesity by altering the adipokine levels and downregulates expression of transcription factors and lipogenic enzymes involved in lipid metabolism.||High fat diet - induced mice|
|Bean||Reductions glucose-6-phosphate dehydrogenase, malic enzyme, fatty acid synthetase, as well as acetyl-CoA carboxylase. The extract decreases appetite and HF diet-induced body weight gain through leptin-like STAT3 phosphorylation and AMPK activation.||Diet-induced obese mice|
|53||Gymnema sylvestre(Retz.) R.Br. ex Sm
|Leaves||Inhibits serum lipids, leptin, insulin, glucose, apolipoprotein B and LDH levels while it increases the HDL-cholesterol, apolipoprotein A1 and antioxidant enzymes levels.||High fatdiet-inducedobesity in wistar rats|
|Leaves||It decreases serum cholesterol, triglycerides, LDL-C, SGOT and SGPT activities.||High cholesterol diet induced obesity in female albino rats|
|Leaf||Promotes LXRα/ABCA1 pathway, stimulating cholesterol removal from macrophages, delaying atherosclerosis. Also, the extract treatment attenuated liver steatosis, downregulated SREBP-1c and PPAR-γ, blocked the increase of IL-1, TNF-α mRNA and lipoperoxidation and increased catalase mRNA.||High fat diet-induced obese C57BL/6NHsd mice|
|56||Holoptelea integrifolia(Roxb.) Planch.
|Bark||HMG-CoA reductase activity is reducedand cholesterol biosynthesis and increase in lecithin, cholesterolacyltransferaseactivity.||Diet-induced obese rat|
|Female inflorescence||Hepatic fatty acid synthesis is reduced through the reduction of hepaticSREBP1cmRNA expression in the rats fed a high-fat diet.||High-fat diet induced obese rat, male C57BL/6J mice fed a HF diet|
|58||Hunteria umbellata(K.Schum.) Hallier f.
|Seed||The extract reduces weight gain pattern and causes dose related reductions in the serum lipids, Coronary artery risk index.Also,pre-treatment significantly improves triton-induced hepatic histological lesions.||High fat diet- induced rats|
Schltdl. & Cham.
|Leaves||Decreases body weight and serum glucose levels. It also decreases total cholesterol, triglycerides and high-density lipoprotein-cholesterol without changing low-density lipoprotein-cholesterol, AI, AST and ALT level.||Male Wistar rats fed with high fat diet|
|Leaves||Body weight and serum glucose levels of the rats decreased. The drug also has effect on total cholesterol, triglycerides and high-density lipoprotein-cholesterol.||Male Wistar rats fed with high fat diet|
|Leaves and unripe fruits||Down-regulates expression of Creb-1 andC/EBPa, and up-regulates expression of Dlk1, Gata2, Gata3, Klf2, Lrp5, Pparc2, Sfrp1,Tcf7l2, Wnt10b, and Wnt3a.The mRNA levels of PPAR-γ2 were downregulated.||High fat diet- induced mice, male Wistar rats fed diet|
|62||Ipomoea batatas(L.) Lam
|Fruit||Expression of SREBP-l, Acyl-CoA Synthase, Glycerol-3-Phosphate Acyltransferase, HMG-CoA Reductase and Fatty Acid Synthase in liver tissue in mice is altered.||Mice fed with high-fat diet|
|Whole Plant||Expression of the fat intake-related gene ACC2 and lipogenesis-related genes are reduced. It increases phosphorylation of AMPKand its direct downstream protein,acetylcoenzyme A carboxylase.||High-fat-diet-induced obese male Sprague-Dawley rats|
(Du Roi) K.Koch
|Whole Plant||Stimulates glucose uptake, potentiated adipogenesis, activated AMPK, and acted as mitochondrial uncoupler/inhibitor (on normal isolated mitochondria).||Diet-induced obese C57BL/6 mice|
|65||Ligularia fischeri(Ledeb.) Turcz.
|Leaves||Polyphenols present in the extract exhibits antiobesity effects by inhibiting pancreatic lipase.||C57BL/6 mice|
|Fruits||Treatment with the extract decreases HFD-induced obesity, mainly by improving metabolic parameters, such as fats and triglycerides.||High fat-diet-induced C58BL/6J obese mice|
(Wall. ex A.DC.) Rehder
|Leaves||Decreases levels of serum lipids, attenuates body weight gain and lowers circulatingleptin and insulin levels, ameliorate the state of oxidative stress, raise serum adiponectin, reduce circulating CRP and resistin levels, and depresses expression of PPARγ and C/EBPα.||High fat diet-induced obese rats|
Siebold & Zucc.
|Roots||Reduces high-fat diet-induced increases in body weight, white adipose tissue mass, serum triglyceride and total cholesterol levels, and hepatic lipid levels and decreases lipogenic and adipogenic gene expression. Acetylshikonin, active constituent of L. erythrorhizon suppresses adipocyte differentiation and attenuates adipogenic transcription factor expression.||C57BL/6J mice were fed a normal or high-fat diet|
|Fruit||Reduces body weight and fat mass. It increases glucose tolerance and reduced plasma triglycerides level.||High-fat diet-induced obesity in mice|
|Fruit, leaves||The hepatic peroxisome PPAR-R and carnitine palmitoyltransferase-1 are elevated, while fatty acid synthase and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase are reduced. It decreases hepatic lipids, fatty acid synthase and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and elevates hepatic peroxisome PPAR-α and carnitine palmitoyltransferase-1.||High fat diet- induced mice, 6-week-old male hamsters.|
|Fruit||Reduces resistance to insulin, associated with leptin.||Male C57BL/6 mice fed with high-fat diet|||
|Fruit, leaves,||Proinflammatory cytokines MCP-1 and TNF-α, plasma triglyceride, liver lipid peroxidation levels and adipocyte size are decreased. Inflammatory markers (monocyte chemoattractant protein-1, inducible nitric oxide synthase, C-reactive protein, tumour necrosis factor-α and interleukin-1) in liver and adipose tissue are increased.||Adenovirus 36-induced obesity in mice, high-fat (HF) diet-induced obese mice.||[116-120]|
|73||Murraya koenigii(L.) Spreng.
|Leaves||Reduces body weight gain, plasma total cholesteroland triglyceridelevels in mice.||High fat diet -induced mice|||
|Fruit||Reduces animal body weights of the fat in white adipose tissues, glucose, total cholesterol, triglycerides, and LDL-c and insulin blood levels. An increase in HDL-c levels also seen.||Wistar rats with obesity induced by subcutaneous injection of monosodium glutamate|||
|Leaves||The body weight reduced by 32 % when administered with sibutramine, while it was reduced by 21 % and 24 % when administered with the methanolic extract of M. communis/kg body weight.||High-fat diet induced obese mice|||
|Seed epicarp, leaves, seed, petals||The extracts effective in inhibiting preadipocyte differentiation. The flavonoids inhibits effect on both adipocyte differentiation and pancreatic lipase activity, accumulation and decreases expression PPARγ, GLUT4, and leptin in cultured human adipocytes, indicating that it inhibits the differentiation of pre-adipocytes into adipocytes. The methanol extract inhibitslipase activity and suppresses the expression of fatty acid synthase, acetyl-CoA carboxylase, and HMGCoA reductase and increases the phosphorylation of AMP-activated protein kinase in the liver.||High fat diet- induced mice
Male Sprague-Dawley rats were fed with a normal diet and a high-fat diet,
High fat diet - induced C57BL/6 mice.
|Fruit||The expression of Igf-1 and Igf-1R were reduced on obese rat model treated with extract of N. lappaceum.||Rat fed with high calorie diet and treated with ellagic acid|||
|78||Nitraria retusa(Forssk.) Asch.
|Shoot||The extract supresses increase in body and fat mass weight, and decreases triglycerides and LDL-cholesterol levels and enhances gene expression related to lipid homeostasis in liver showing anti-obesity actions.||BKS.Cg-Dock7m+/+ Leprdb/J mice model|||
|Leaves||The extract reverses HFD-induced upregulation of WNT10b- and galanin-mediated signaling molecules and key adipogenic genes (PPARγ, C/EBPα, CD36, FAS, and leptin). It also induces downregulation of thermogenic genes involved in uncoupled respiration (SIRT1, PGC1α, and UCP1) and mitochondrial biogenesis (TFAM, NRF-1, and COX2).||High-fat diet-induced obesity in mice||[130,131]|
|80||Orthosiphon aristatus (Blume) Miq
|Whole plant||Betulinic acid, the active constituent suppresseshypothalamic protein tyrosine phosphatase 1B in mice and enhances the antiobesity effect of leptin in obese rats||High-fat-fed mice|||
|Root||Ginsam increases PPAR- γ expression and AMP-activated protein kinase phosphorylation in liver and muscle. The extracts stronglyactivatesHormone Specific Lipasevia Protein Kinase A.||Insulin - resistant rat, high fat diet induced obese C57BL6/J mice||[133,134]|
|Leaf||It decreases body weight gain, food efficiency ratio, and relative liver and epididymal fat mass.||High fat diet - induced rats|||
(Siebold & Zucc.) Maxim.
|Flower buds||The extracts attenuate three adipogenetic transcription factors,peroxisome PPAR-γ2, CCAAT/ enhancer- binding protein and sterol regulatory element- binding protein 1c.||Diet- induced obesity-prone mice.|||
|Bean||It reduces food intake and body weight in an animal model of obesityresulting in suppression of glycaemia.||Genetically obese adult male Zucker fa/fa rats.|||
|85||Phyllostachys edulis(Carrière) J.Houz.
|Leaves||The extract ameliorates elevated MCP-1 concentration in the blood.||High fat diet - induced C57BL/6J mice|||
|86||Pinus koraiensisSiebold & Zucc
|Leaves||Suppresses fat accumulation and intracellular triglyceride associated with downregulation of adipogenic transcription factor expression, including PPARγ and CEBPα in the differentiated 3T3-L1 adipocytes. It attenuates expression of FABP and GPDH as target genes of PPARγ during adipocyte differentiation.||High fat diet Male Sprague-Dawley rats|||
|Seed||P. fragile rude oil shows significant reduction in body weight.||Male Sprague dawley mice were treated with high cholesterol diet|||
|leaves||P. sarmentosum group shows reduction in enzyme activity. Aqueous extract of P. fragile have the ability to reduce 11β-HSD1 enzyme activity.||Ovariectomy-Induced Obese Rats|||
|Roots||Platycodin feeding increases cholesterol absorption up to 60%, but not cholesterol synthesis. Platycodin-enriched diets can lower circulating and whole body cholesterol contents.||Golden Syrian hamsters|||
|Aerial Parts||Extract of P. aviculare suppresses the elevated mRNA expression levels of sterol regulatory element-binding protein-1c, peroxisome PPAR-γ, fatty acid synthase, and adipocyte protein 2 in the white adipose tissue of obese mice.||High-fat dietinduced obese mice|||
|Whole Plant||Salicortin reduces whole body and retroperitoneal fat pad weights, as well as hepatic triglyceride accumulation. It also modulates key components in signaling pathways involved with glucose regulation and lipid oxidation in the liver, muscle, and adipose tissue.||C57Bl/6 mice subjected to high fat diet|||
|Roots||A significant decrease in the levels of serum glucose, triglyceride, total cholesterol, LDL and VLDL observed in the animals treated with the extract of P. integrifolia.||Female Swiss Albino mice, fed with cafetaria diet|||
|93||Prunus mume (Siebold) Siebold & Zucc
|Fruit||Increases CPT-1 expression and decreases FAS, ACC, and SREBP-1c in the liver and quadriceps muscles to resulting in reducing triglyceride accumulation. It also improves insulin sensitivity in OVX rats and prevents the impairment of energy, lipid, and glucose metabolism by OVX through potentiating hypothalamic leptin and insulin signaling.||High fat diet, ovariectomized rats|||
|94||Pueraria montana var. chinensis (Ohwi) Sanjappa & Pradeep
|Flower||It downregulates acetyl-CoA carboxylase expression. For adipose tissue, the expressions of hormone-sensitive lipase in white adipose tissue and uncoupling protein 1 in brown adipose tissue are upregulated.||Male C57BL/6J mice were fed a high-fat diet|||
|Leaves, seed||Punicic acid binds and activates PPAR-α and γ, thus upregulating PPAR α and its responsive genes (Stearoyl-CoA desaturase-1, SCD1; Carnitine palmitoyltransferase 1, Cpt-1; and acyl-coenzyme A dehydrogenase) as well as PPAR γ-responsive genes expression (CD36 and Fatty Acid Binding Protein4, FABP4) in intra-abdominal white adipose tissue while suppressing expression of the inflammatory cytokine TNF-α and NF-κB activation.||High-fat diet induced obese mice||[147,148]|
|Root||It inhibits peroxisome PPAR-γtransactivity and the expression of its target genes, suggesting that rhein acts as a PPARγ antagonist.||Diet-induced obesefemale C57BL/6 mice||[108,149, 150]|
|Leaves||It decreases circulating tumor necrosis factor alpha, IL-1β, and leptin, and upregulated adiponectin. The extract also induces phase I and phase II gene expression and the peroxisome PPAR-γ coactivator 1-alpha. Serum triglycerides, cholesterol and insulin levels are also decreased in the lean animals.||Lean (Le,fa/+) and obese (Ob,fa/fa) female Zucker rats|||
|Fruit||Purified blueberry anthocyanins have been shown to improve body weight and body composition and reduce obesity in mice.||C57BL/6J
mice fed a high-fat diet
|Pericarp of flower||Methanolic extract decreases body weight, BMI, Blood glucose levels, total cholesterol, LDL-C, HDL-C, Triglycerides, SGOT, and SGPT.||Monosodium glutamate induced obesity in wistar albino rats|||
|Leaves||Adipogenesis is inhibited by this drug by downregulating the expression of CCAAT/enhancer-binding protein α, peroxisome PPAR-γ, SREBP-1c, and aP2. It also decreases the expression of fatty acid synthase and adiponectin mRNAs in differentiating adipocytes. It increases AMPK and acetyl-CoA carboxylasephosphorylation.||High-fat diet-induced obese C57BL/6 mice||[154,155]|
|101||Schisandra chinensis(Turcz.) Baill.
|Peel||It decreases expression of C/EBPβ,C/EBPα or PPARγ, and resultant down-regulation of the terminal marker gene, aP2 during differentiation of 3T3-L1 preadipocytes into adipocytes. Akt and GSK3β phosphorylation are down-regulated blocking adipogenesis and adipocyte differentiation.||HFD-induced obese rats|||
|102||Senna siamea (Lam.) H.S.Irwin & Barneby
|Roots||Active constituents includes chrysophanol, physcion, emodin, cassiamin A, friedelin and cycloart-25-en-3,24- diol exhibits pancreatic lipase inhibitory activity.||Alloxan induced diabetes rats.|||
|Leaves||It decreasesserum glucose, triglyceride, cholesterol, LDL-C, HDL-C, VLDL-C, atherogenic index, SGPT and SGOT.||Monosodium glutamate induced obesity in albino rats|||
|104||Sida rhombifolia L.
|Leaf||Up-regulation of PPARγ 2 and SREBP-1cexpression in the epididymal adipose tissue, leading to attenuation of adipogenesis.||High fat diet- induced C57BL/6J mice|||
|Fruit||AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation in liver is elevated, and HMG-CoA reductase expression is decreased. It strongly decreases expression of peroxisome PPAR-γ, CCAAT/enhancer-binding protein alpha and perilipin in the adipose tissue.||High-fat-diet-induced obesity in C57BL/6 mice||[160,161]|
|106||Syzygium aromaticum(L.) Merr. & L.M.Perry
|Flower buds||The extract suppresses expression of lipid metabolism-related proteins, including SREBP-1, FAS, CD36 and PPARγ in the liver and WAT, in addition to downregulates mRNA levels of transcription factors including SREBP and PPAR-γ.||Highfatdiet fed mice|||
|Fruit pulp,pulp, seed coat||Levelsof plasma total cholesterol, lowdensity lipoprotein, andtriglyceride is decreased and it increases high-density lipoprotein, with the concomitant reduction of body weight.||Diet-induced obese Sprague-Dawley rats||[163-165]|
|108||Tecomella undulata(Sm.) Seem.||Bark||The extract shows a significant increase in SIRT1 and adiponectin levels and decrease in PPAR, C/EBP, E2F1, leptin and LPL levels in preadipocytes and adipocytes and shows improvement in lipid profile and glucose levels.||High Fat Diet obese mice.|||
|Peel||It inhibits lipid accumulation and decreases expression of C/EBPβ, as well as the C/EBPα and PPARγ genes during the differentiation of preadipocytes into adipocytes. It down-regulates adipocyte-specific genes such as aP2 and FAS.||High-fat diet-induced obese rats|||
|Whole plant||It reduces weight gain and the fat pad weight in high fat diet-induced obese mice.||High-fat diet-induced obese mice|||
(Willd.) Ohwi & H.Ohashi
|Seed||It reduces total hepatic lipid accumulation and lipid secretion into the feces. Incubation of adipocytes with the extract significantly decreases triglyceride accumulation, glycerol phosphate dehydrogenase activity and inflammatory responses without affecting cell viability.||High fat diet-induced obesity in rats|||
|112||Vigna nakashimae(Ohwi) Ohwi & H.Ohashi
|Seeds||It decreases expression of peroxisome proliferator activated receptorγ and its target genes. It enhances the phosphorylation of AMP-activated protein kinase (AMPK) and acetyl CoA carboxylase (ACC), and increases the expression of fatty acid oxidation genes.||High-fat dietfed mice|||
|Leaves, stems, and fruits||Body and epididymal fat pad weights are, andhistologicalexamination indicates an amelioration of fatty liver. It potently induces mitochondrial activity by activating thermogenesis and improving endurance capacity and also inhibited adipogenic factors in vitro.||Male C57Bl/6 mice fed a high-fat diet|||
Siebold & Zucc
|Roots||Activation of AMPK activating glucose and lipid metabolism.||High-fat diet-fed C57BL/6JNarl mice|||
|Seed flours, peel, roots, fruit||By up-regulating hepatic genes related to cholesterol (CYP51) and bile acid (CYP7A1) synthesis as well as LDL-cholesterol uptake. Lipid metabolism-associated genes Mlxp1, Stat5a, Hsl, Plin1, and Vdr were down-regulated. The extract treatment decreases expression of aP2, Fas, and Tnfa, known markers of adipogenesis, as measured by real-time polymerase reaction.Expression ofPPAR-γin liver and adipose tissue is lowered by regulating the lipid metabolism and suppressed obesity.||Male Golden Syrian hamsters fed high-fat (HF) diets, high fat diet - induced C57BL/6J mice||[54,171-178]|
|116||Zanthoxylum bungeanum Maxim.
|Fruit||It reduces weight gain, white adipose tissue mass, and serum triglyceride and cholesterol levels. It also decreased lipid accumulation and PPARγ, C/EBPα, SREBP-1, and FAS protein and mRNA levels in the liver.||Obese C57BL/6 mice fed a high-fat diet|||
|Bark||It reduces body weight, fat mass and pancreatic lipase activity.||High Fat Dietinduced obesity in Wistar rats|||
|118||Dohaekseunggi-tang traditional plant-based medicine(Taohe Chengqi Tang: Chinese)||Commercial formula||Dohaekseunggi-tang consists of five herbs includingGlycyrrhizae uralensisFischer (40g),Rheum undulatumLinne (80g),Prunus persicaLinne (60g),Cinnamomum cassiaPresl (40g), and Natrii Sulfas (40g) mixed. The extract decreased serum total cholesterol, LDL-cholesterol,triglyceride, glucose, and leptin concentrations, and increased HDL-cholesterol and adiponectin levels and increased mRNA expression of peroxisome proliferator activated receptor-γ, uncoupling protein-2, and adiponectin in visceral adipose tissue of HFD mice||High-fat dietinduced obese mice|||
Table 1: Anti-obesity effect of natural occurring plants with mechanism of action studied on animal models
|1||Acorus calamusLinn (Araceae)||Rhizome, roots and leaves||Ethyl acetate extract of A. calamus inhibits α-glucosidase activity.||HTT-T15 cell line|||
|2||Aegle marmelosLinn (Rutaceae)||Leaves||Active compounds umbelliferone and esculetin depletes lipid content in the adipocytes and by decreasing the hyperlipidemia in obese rats fed with high-fat diet.||3T3-L1 preadipocytes||[30,31]|
|3||Agrimonia pilosaLedeb (Rosaceae)||Aerial parts||Active constituent 1beta-hydroxy-2-oxopomolic acidinhibits adipocyte differentiation and expression of adipogenic marker genes, such as PPAR-γ, C/EBPalpha, GLUT4, adiponectin, aP2, ADD1/SREBP1c, resistin, and fatty acid synthase. It also inhibits adipocyte differentiation through downregulation of various adipocytokines by blocking PPAR-γ and C/EBPalpha expression.||3T3-L1 preadipocytes|||
|4||Alnus hirsuta (Spach) Rupr. (Betulaceae)||Leaves||Platyphyllonol-5-O-β-d-xylopyranosidesuppresses the induction of PPARγ and C/EBPα protein expression, and inhibits adipocyte differentiation.||3T3-L1 preadipocyte cells|||
|5||Amomum cardamomumL. (Zingiberaceae)||Seeds||By regulating the C/EBPα, C/EBPβ and PPARγ gene and protein expressions.||3T3-L1 Cell lines.|||
|6||Bauhinia variegateL. (Fabaceae)||Flowers, flower buds, stem, roots, stem bark, seeds, leaves||itreduces increased level of total cholesterol, triglycerides, LDLP and increases the level of HDLP, brain serotonin level. β -sitosterol in the stem induces secretion of serotonin in brain and in turn exhibits anti-obesity activity.||Human neutrophils.|||
|7||Brassica rapa L. (Brassicaceae)||Root||Lipolysis-related genes includingβ3-adrenergic receptor,hormone-sensitive lipase,adipose triglyceride lipase, anduncoupling protein are induced in white adipocytes of animals treated with extract of B. campestris. Activation of cyclic AMPK, HSL, and extracellular signal-regulated kinase are induced in EBR-treated 3T3-L1 cells.||3T3 adipocytes.|||
|8||Caesalpinia sappanL. (Leguminosae)||Heartwood||Brazilein inhibits intracellular lipid accumulation during adipocyte differentiation in 3T3-L1 cells and suppresses the induction of peroxisome PPAR-γ (PPARγ).||Postconfluent 3T3-L1 preadipocytes|||
|9||Citrus aurantiumL. (Rutaceae)||Fruits, leaves||It inhibits Akt activation and GSK3β phosphorylation, which induces the down-regulation of lipid accumulation and lipid metabolizing genes, ultimately inhibiting adipocyte differentiation.||3T3-L1 preadipocytes||[22,187,188]|
|10||Coptis chinensis Franch. (Ranunculaceae)||Rhizome||It inhibits lipid accumulation in 3T3-L1 cells. The five alkaloids present in this plant significantly reduces expression levels of several adipocyte marker genes including proliferator activated receptor and CCAAT/enhancer- binding protein. Isolated alkaloids found to inhibitadipogenesis.||3T3-L1 adipocytes cells|||
|11||Cucurbita moschataDuchesne (Cucurbitaceae)||Stems||Reduces expression of peroxisome PPAR-γ, CCAAT/enhancer-binding protein α, fatty acid-binding protein 4, sterol response element-binding protein-1cand stearoyl-coenzyme A desaturase-1, and decreases lipid accumulation.||Primary mouse embryonic fibroblasts|||
|12||Curcuma longaL. (Zingiberaceae)||Rhizomes||Increase hormone-sensitive lipase and adipose triglyceride lipase mRNA levels and decreases perilipin mRNA level via AMPK, resulting in lipolysis.In adipose tissue, curcumin inhibits macrophage infiltration and nuclear factor κB activation induced by inflammatory agents.||3T3-L1 adipocytes||[191,192]|
|13||Cyclopia falcata (Harv.) Kies (Leguminosae)||Stem||Flavonoid, phloretin-3′,5′-di-C-glucosideinhibits intracellular triglyceride and down regulates PPAR2 expression and in in vitro condition it can inhibit adipogenesis.||3T3-L1 mouse pre-adipocytes|||
|14||Cyclopia maculata(Andrews) Kies (Leguminosae)||Stems||Mangiferin, hesperidin inhibits intracellular triglyceride and fat accumulation, and decreases PPAR2 expression and in in vitroit can inhibit adipogenesis.||3T3-L1 mouse pre-adipocytes|||
|15||Dalbergia sissooDC. (Leguminosae)||Leaves||Inhibits pancreatic lipase and can be used as an anti-obesity agent in suitable form.||Chicken pancreas|||
|16||Dioscorea oppositifolia L. (Dioscoreaceae)||Rhizome||Decreases expression of PPAR-γ. Batatasin I compound from the extract was found to increase p-AMPK and CPT-1 in 3T3-L1 adipocytes, resulting in inhibiting adipogenesis.||Mouse embryo preadipocyte (3T3-L1) cell lines|||
|17||Eremochloa ophiuroides (Munro) Hack (Poaceae)||Whole Plant||Expression of C/EBP and PPAR, the central transcriptional regulators of adipogenesis. Moreover, this plant down-regulates phosphorylation levels of Akt and GSK3.||Mouse 3T3-L1 preadipocytes|||
|18||Glycine max(L.)Merr. (Leguminosae)||Bean||It inhibits adipocyte differentiation in 3T3-L1 preadipocyte cells. Accumulation of triglycerides is inhibited and activation of AMPK.||3T3-L1 preadipocyte cells||[89,90]|
|19||Houttuynia cordataThunb. (Saururaceae)||Leaf||Attenuates expression of fatty acid synthase, sterol regulatory element-binding protein-1 and glycerol 3-phosphate acyltransferases. The extract inhibits the elevation of plasma TG levels in mice. The extractspossibly suppress the uptake of NEFA and glycerol by blocking FAT/CD 36 and also suppress aquaproin-7.||Human HepG2 hepatocytes||[197,198]|
|20||Ilex paraguariensis A.St.-Hil. (Aquifoliaceae)||Leaves and unripe fruits||A modulatory effect on the expression of genes related to the adipogenesis as PPAR2, leptin, TNF and C/EBP are also seen.||3T3-L1 cell line||[102-105]|
|21||Ipomoea batatas(L.) Lam (Convlvulaceae)||Fruit||Expression of SREBP-l, Acyl-CoA Synthase, Glycerol-3-Phosphate Acyltransferase, HMG-CoA Reductase and Fatty Acid Synthase in liver tissue.||Murine 3T3-LI adipocytes|||
|22||Irvingia gabonensis (Aubry-Lecomte ex O'Rorke) Baill. (Irvingiaceae)||Seed||Inhibits adipogenesis in adipocytes. The effect appears to be mediated through the down regulated expression of adipogenic transcription factors (PPAR-γ)and adipocyte-specific proteins (leptin), and by upregulated expression of adiponectin.||Murine 3T3-LI adipocytes|||
|23||Morus australis Poir. (Moraceae)||Root||Increases lipolytic effects such as decreased intracellular triglyceride and the release of glycerol.||3T3-L1 adipocytes|||
|24||Nelumbo nuciferaGaertn. (Nelumbnaceae)||Seed epicarp, leaves, seed, petals||The extracts effective in inhibiting preadipocyte differentiation. The flavonoids inhibits effect on both adipocyte differentiation and pancreatic lipase activity, accumulation and decreases expression PPARγ, GLUT4, and leptin in cultured human adipocytes, indicating that it inhibits the differentiation of pre-adipocytes into adipocytes.||3T3-L1 (adipocyte), NIH3T3 (mouse fibroblast, embryo), L-02 (normal hepatocyte) cells CHO-K1, and U2OS cells,||[124-127]|
|25||Nepeta tenuifolia Benth. (Lamiaceae)||Whole plant||Inhibits triglyceride accumulation in 3T3-L1 adipocytes, suggesting anti-obesity activity.||3T3-L1 cells|||
|26||Pericarpium zanthoxyli (Rutaceae)||Seed||Decreases expression of the adipogenesis-related transcription factor,PPAR-γ and PPAR-γ-target genes, such as adipocyte protein 2 (aP2), fatty acid synthase (FAS) and other adipocyte markers and also decreases levels of CCAAT/enhancer-binding protein β (C/EBPβ) in a dose-dependent manner.||OP9 cells|||
|27||Petasites japonicus (Siebold & Zucc.)||Flower buds||The extracts attenuate three adipogenetic transcription factors,peroxisome PPAR-γ2, CCAAT/ enhancer- binding protein and sterol regulatory element- binding protein 1c.||3T3-L1 murine preadipocytes|||
|28||Peucedanum japonicumThunb. (Apiaceae)||Leaves||Pteryxin down regulates genes SREBP-1c, fatty acid synthase, and acetyl-coenzyme A carboxylase-1 in treated 3T3-L1 adipocytes and HepG2 hepatocytes and up-regulates lipid catabolizing genes. In aother study it was proved that the extract down-regulates a key lipogenic activator, SREBP1 c and adipocyte size marker gene, paternally expressed gene 1/mesoderm-specific transcript (PEG1/MEST) in adipose tissue in vivo.||Both 3T3-L1 and HepG2 cell lines, 3T3-L1 and HepG2 cells||[203,204]|
|29||Rubus chingii var. suavissimus (S.K.Lee) L.T.Lu (Rosaceae).||Leaves||The extract increases adipogenesis and increases expression of adiponectin and leptin. In the early phase of adipogenesis, extract increases the mRNA expression of adipogenic transcription factors CCAAT/enhancer binding protein α and PPAR-γ.||3T3-L1 preadipocytes|||
|30||Salicornia herbaceaL. (Amaranthaceae)||Whole plant||Isorhamnetin 3-ÃÂ-β-D-glucopyranoside suppresses adipogenic differentiation by downregulation of peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding proteins, SREBP1, and the adipocyte-specific proteins. Specific mechanism mediating the effects of isorhamnetin 3-ÃÂ-β-D-glucopyranoside confirmed by activation of AMPK.||3T3-L1 preadipocytes|||
|31||Siegesbeckia pubescensL. (Amaranthaceae)||Whole plant||The anti-obesity effect is modulated by cytidine-cytidine-adenosine-adenosine-thymidine/enhancer binding proteins, and peroxisome proliferator-activated receptor, gene and protein expressions.||3T3-L1 preadipocytes|||
|32||Smilax chinaL. (Smilacaceae)||Leaves||Polyphenol and flavonoid, exhibits α-glucosidase and lipid accumulation inhibition properties.||3T3-L1 adipocytes|||
|33||Tetrapanax papyriferus (Hook.) K.Koch (Araliaceae)||Whole plant||The anti-obesity effect is modulated by cytidine-cytidine-adenosine-adenosine-thymidine/enhancer binding proteins, and peroxisome proliferator-activated receptor, gene and protein expressions.||3T3-L1 preadipocytes|||
|34||Veratrum nigrumL. (Melanthiaceae)||Whole plant||It decreases lipid accumulation and the expressions of two major adipogenesis factors, PPAR and C/EBP, in 3T3-L1 cells.||3T3-L1 cells|||
|35||Vitis labruscaL. (Vitaceae)||Seed||The extract of V. labrusca inhibits lipid accumulation of C3H10T1/2 and 3T3-L1 cells in a dose-dependent manner. Inhibition is associated with reduced expression of PPAR-γ.||C3H10T1/2 and 3T3-L1 cells|||
|36||Vitis viniferaL. (Vitaceae)||Seed flours, peel, roots, fruit||By up-regulating hepatic genes related to cholesterol (CYP51) and bile acid (CYP7A1) synthesis as well as LDL-cholesterol uptake. Lipid metabolism-associated genes Mlxp1, Stat5a, Hsl, Plin1, and Vdr were down-regulated. The extract treatment decreases expression of aP2, Fas, and Tnfa, known markers of adipogenesis, as measured by real-time polymerase reaction.Expression ofPPAR-γin liver and adipose tissue is lowered by regulating the lipid metabolism and suppressed obesity.||3T3-L1 preadipocytes, high fat diet- induced mice, murine 3T3-LI adipocytes,||[54,171-178]|
|37||Ziziphus jujubeMill. (Rhamnaceae)||Fruit||Suppresses lipid accumulation and glycerol-3-phosphate dehydrogenase. Elicits the most inhibitory effect with attenuation of the expression of key adipogenic transcription factors, includingPPAR-γ and CCAAT enhancer binding proteins (C/EBPs) at the protein level.||3T3-L1 preadiocytes||[209-211]|
|38||Germinated brown rice, germinated waxy brown rice, germinated black rice, and germinated waxy black rice||Seed||Extract of these seeds decreases body weight gain and lipid accumulation in the liver and epididymal adipose tissue. The mRNA levels of adipogenic transcriptional factors, such as CCAAT enhancer binding protein (C/EBP)-α, SREBP(SREBP)-1c, and peroxisome proliferator activated receptors (PPAR)-γ, and related genes (aP2, FAS) are decreased by the seed extract.||3T3-L1 murine adipocytes|||
Table 2: Anti-obesity effect of plants with mechanism of action studied on cell line as model.
|1||Carum carviL. (Apiaceae)||Seed||Reduces weight, body mass index, body fat percentage, and waist-to-hip ratio.||Human clinical trials|||
|2||Cissus quadrangularisL. (Vitaceae)||Cylaris a formula contains a C. quadrangularextract||Phytosterols and fiber extracts have anti-lipase, and anorexiant properties that reduce the absorption of dietary fats and enhance satiation by increasing serum serotonin levels.||Human clinical trials|||
|3||Citrus aurantiumL. (Rutaceae)||Fruits, leaves||The active constituent p-synephrine increases metabolic rate, energy expenditure and increase in weight loss. The leaf extract down-regulates the expression of C/EBPβ and subsequently inhibits the activation of PPARγ and C/EBPα. The anti-adipogenic activity of is mediated by the inhibition of Akt activation and GSK3β phosphorylation, which induces the down-regulation of lipid accumulation and lipid metabolizing genes, ultimately inhibiting adipocyte differentiation.||Human clinical trials||[22,187,188]|
|4||Garcinia cowa Roxb. ex Choisy (Clusiaceae)||Fruit, commercially available tablet||Inhibits the enzyme ATP-dependent citrate lyase, which catalyzes the cleavage of citrate to oxaloacetate and acetyl-CoA.Serum apo A1 levels are increased by the plant and the serum total cholesterol levels.||Human clinical trials||[86,87]|
|5||Gynostemma pentaphyllum (Thunb.) Makino (Cucurbitaceae)||Leaves||Activation of AMPK by 5-aminoimidazole-4-carboxamide- 1-b-D-ribofuranoside (AICAR) inhibits adipogenesis by downregulating PPARcand CEBP1a as well as lipogenic factors including fatty acid binding protein 4 and lipoprotein lipase. AMPK activation directly inactivates ACC through Ser79 phosphorylation, leading to decreased fat synthesis by reducing the production of malonyl-CoA from acetyl-CoA.||Human clinical trials|||
|6||Nigella sativaL. (Ranunculaceae)||Commercial Nigella sativa oil prepared by steam distillation.||N. sativa reduces total cholesterol, low density lipoprotein (LDL) and fasting blood glucose. The oil is effective as an add-on therapy in patients with metabolic syndrome.||Human Volunteer||[216,217]|
|7||Salacia reticulatawight (Celastraceae)||Root||Significant weight and body-fat reduction was observed in S. reticulatatreated animals and also BMI reduction is seen.||Human clinical trials|||
|8||Trigonella foenum-graecumL. (Leguminosae)||Seed||Daily fat consumption, expressed as the ratio fatreported energy intake/total energy expenditure (fat-REI/ TEE), is decreased in overweight subjects administered the fenugreek seed extract. Significant decrease in the insulin/glucose ratio in subjects treated with fenugreek seed extract.||Clinical trials|||
|9||Turnera diffusa Willd. ex Schult. (Passifloraceae)||Leaves||The herbal preparation capsules delays gastric emptying, reducing the time to perceived gastric fullness and induces weight loss.||Healthy volunteers||[220,221]|
|10||Vernonia amygdalinaDelile (Compositae)||Leaf||Fat eliminationusually occurred within 2 sec, 2 min of extract intake. The blood glucose lowers effects of V. amygdalina leaf extract were usually exerted in 2 sec, 2 min of extract intake by the patient.||Clinical trials|||
|11||Ziziphus jujubeMill. (Rhamnaceae)||Fruit||The extract suppresses lipid accumulation and glycerol-3-phosphate dehydrogenase. Z. jujuba extract elicits the most inhibitory effect with attenuation of the expression of key adipogenic transcription factors, includingPPAR-γ and CCAAT enhancer binding proteins (C/EBPs) at the protein level.||Human clinical trials||[209-211]|
Table 3: List of plants exhibiting anti-obesity activity studied on human volunteers.
|1.||Verbesina persicifoliaDC (Compositae)||Aerial parts||4β-cinnamoyloxy,1β,3α-dihydroxyeudesm-7,8-ene is the active constituent present in V. persicifolia induces bioenergetic collapse in rat liver mitochondria, demonstrating typical uncoupling agent. It acts as a mild uncoupler droping Δψ and increases respiratory state 4. The energy collapse, mild uncoupling, and the fact that V. persicifolia is largely used in folk medicines, this plant may be viewed as a potentially effective anti-obesity drug.||Rat liver mitochondria|||
Table 4: Anti-obesity effect of plants with mechanism of action studied on isolated cell organelles.
|1.||Fraxinus chinensis subsp. rhynchophylla (Hance) A.E.Murray(Oleaceae)||Stems and barks||Major active components are secoiridoids ligstroside, oleuropein, 2"-hydroxyoleuropein and hydroxyframoside B. These compounds significantly inhibit pancreatic lipase and hydroxyframoside B being the most active inhibitor in a mixed mechanism of competitive and noncompetitive manner.||Porcine pancreatic lipase|||
|2||Vitis viniferaL.(Vitaceae)||Seed flours, peel, roots, fruit||By up-regulating hepatic genes related to cholesterol (CYP51) and bile acid (CYP7A1) synthesis as well as LDL-cholesterol uptake. Lipid metabolism-associated genes Mlxp1, Stat5a, Hsl, Plin1, and Vdr were down-regulated. The extract treatment decreases expression of aP2, Fas, and Tnfa, known markers of adipogenesis, as measured by real-time polymerase reaction.Expression ofPPAR-γin liver and adipose tissue is lowered by regulating the lipid metabolism and suppressed obesity.||Pure pancreatic lipase||[54,171-178]|
Table 5: Anti-obesity effect of plants with mechanism of action studied on isolated cell enzymes.
In this review, we have report the antiobesity effects of different herbal plants or compounds containing minerals or chemical extracts of plants. Plants having reported antiobesity effects are listed in Table 1 with information about their active components and their effects. From the review it was suggested that, plant showing anti-obesity potential mainly belongs to the family Leguminoseae, Lamiaceae, Liliaceae, Cucurbitaceae, Asteraceae, Moraceae, Rosaceae and Araliaceae. Majority of the studies indicates decrease in body weight or body weight gain in animals and humans with or without changes in body fat indicating antiobesity effects. The antiobesity effects such as body weight reduction, decrease in the levels of triglycerides, total cholesterol, and low density lipoprotein cholesterol with simultaneous increase in high density lipoprotein cholesterol was observed in the animals treated with the plants [1,15,29,31,39,54,60,78,79,83 ,85,98,100,101,133,145,152,165,190,196,201]. In one study , it has been reported that a compound chakasaponin II, suppressed mRNA levels of neuropeptide Y (NPY) and enhanced the release of serotonin (5-HT) that suppressed the appetite signals in the hypothalamus of the mice. Clinical trials were conducted on humans for various plant extracts [45,49,135] which showed a significant decrease in body weight and body fat reduction. There was an increase in metabolic rate and energy expenditure. It was also reported that the clinical trials performed on humans for the plant extracts [151,165,226] showed an excess fat elimination, body mass index, fat percentage and blood glucose lowering effects. In another clinical trial study  the fenugreek seed extract decreased the fat consumption and also insulin/glucose ratio. The essential oil from the plants [124,227] suppressed fat accumulation, intracellular triglyceride and decrease in body weight. Ginseng which is a popular Chinese herbal medicine significantly decreased the weight gain and improved glucose tolerance [115,120]. P. granatum exhibits potential antiobesity mechanism including inhibition of pancreatic lipase activity and suppression of energy intake. Its effect on energy intake was similar to subutramine but with a different mechanism.
A study reported that Green tea possessed higher antioxidant activity than antiobesity activity due to its high concentration of catechins, including epicatechins, ECG and EGCG. It was proved that antiobesity activity of catechins resulted from the combined actions of appetite reduction, greater lipolytic activity, energy expenditure and adipocyte differentiation.
The active compounds umbelliferone and esculetin from the plant Aegle marmelos have shown marked effect by depleting the lipid content in the adipocytes and by decreasing the hyperlipidemia. Similarly, galangin a compound from Alpinia galangal showed a significant decrease in serum lipids, liver weight, lipid peroxidation and accumulation of hepatic Triglycerides. Decursin a compound from Angelica gigas significantly improved glucose tolerance and reduced the secretion of HFD-induced adipocytokines. The phytoconstituent compound sitosterol found in Boerhaavia diffusa is structurally similar to cholesterol has been suggested to reduce cholesterol by lowering the level of LDL-cholesterol. p-synephrine compound from the plant Citrus aurantium showed increased metabolic rate, energy expenditure and increase in weight loss. In Nelumbo nucifera flavonoids showed mild inhibitory effect on both adipocyte differentiation and pancreatic lipase activity. Among the flavonoids, flavones without glucose inhibited pancreatic lipase activity, whereas flavone glycosides did not show inhibition. The presence of ephedrine and pseudoephedrine in the plant Sida rhomboidea induced appetite suppression that inhibits body weight gain.
Natural products identified from traditional medicinal plants have always paved the way for development of new types of therapeutics. Generally most of the compounds were isolated from natural sources despite which orlistat a semi-synthetic derivative of lipstatin have been approved by the US food and drug administration for the treatment of obesity. Orlistat is a potent inhibitor of pancreatic lipase (PL) which is a lipolytic enzyme which hydrolyses dietary fats in the initial step of lipid metabolism. There have been many reports on other effects such as anti-oxidative stress effects which may be important in the management of other diseases like cardiovascular diseases and diabetes. The antiobesity drugs are generally preferred based on high efficacy and effectiveness. The active exploration of natural sources has provided new developments based on the understanding of complex and redundant physiological mechanisms. Such exploration will lead to a safe and effective pharmacological treatment.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : June 25, 2019